AGA guidelines recommend testing for Lynch syndrome in all patients with colorectal cancer

the ONA take:

The American Gastroenterological Association has published a new guideline for colorectal cancer (CRC). The guideline, published in Gastroenterology, recommends all patients with a new diagnosis of CRC should undergo testing for Lynch syndrome.

Lynch syndrome is an inherited disorder in which the MMR gene is mutated, making the body less able to fix errors in the DNA. The syndrome is the most common inherited cause of colorectal cancer, affecting approximately 700,000 Americans. Children have an approximately 50% chance of inheriting the disorder. Most people with the syndrome are not aware that they have it.

Colorectal cancer is the second leading cause of cancer death in the United States. Approximately 30% of persons who develop CRC have a family history of the disease, and 5% to 6% have mutations diagnostic of a known hereditary cancer syndrome. Persons with Lynch syndrome have an 80% higher risk for colorectal cancer and a 60% higher risk for endometrial cancer.

AGA recommends all patients with colorectal cancer get tested for Lynch syndrome
AGA recommends all patients with colorectal cancer get tested for Lynch syndrome
All colorectal cancer patients should undergo tumor testing to see if they carry Lynch syndrome, the most common inherited cause of colorectal cancer, according to a new guideline published in Gastroenterology, the official journal of the American Gastroenterological Association.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs